After-Hours Movers 05/29: (OSIR) (CPRT) Higher; (PWRD) (SURG) (RIMM) (DRYS) Lower

May 29, 2012 6:09 PM EDT Send to a Friend
Get Alerts OSIR Hot Sheet
Trade OSIR Now!
Osiris Therapeutics, Inc. (NASDAQ: OSIR) 19.9% HIGHER; announced today that it has received transitional pass-through status from the Center for Medicare & Medicaid Services, with C-Codes being designated for Grafix®. Further, the product has been assigned pass-through status under Medicare's outpatient prospective payment system, effective July 1, 2012. These codes will assist in facilitating reimbursement when Grafix products are used to treat Medicare patients with acute and chronic wounds in the hospital outpatient department and ambulatory surgical center settings. CMS also issued a preliminary positive decision for the assignment of permanent Healthcare Common Procedure Coding System (HCPCS) Q-codes for Grafix.

Perfect World Co. Ltd. (NASDAQ: PWRD) 10.4% LOWER; reported Q1 EPS of RMB4.52, vs. the analyst estimate of RMB4.64. Revenue for the quarter came in at RMB718.5 million versus the consensus estimate of RMB735.91 million. The company posted EPS of 79 cents per ADS on sales of $114.1 million. Sees Q2 2012 revenue of RMB647-RMB683 million, versus the consensus of RMB783.14 million.

Synergetics USA, Inc. (Nasdaq: SURG) 9% LOWER; offers prelim. Q3 sales of $14.4-$14.7 million, which compares to the Street estimate of $16.1 million. Looking for EPS of 4-6 cents before a 1 cent writedown. Click here to see the full report.

Research In Motion (Nasdaq: RIMM) 8.1% LOWER; said to hire JPMorgan, RBC to advise on options, will no longer issue quantitative guidance, and is now expecting a Q1 loss. The Street is currently looking for EPS of 43 cents for the quarter. Click here for the full report.

Copart, Inc. (NASDAQ: CPRT) 2.8% HIGHER; reported Q3 EPS of $0.43, in-line with the analyst estimate of $0.43. Revenue for the quarter came in at $244.1 million versus the consensus estimate of $259.37 million.

DryShips, Inc. (NASDAQ: DRYS) 1.3% LOWER; reported Q1 non-GAAP loss of $0.11, $0.07 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $247.5 million versus the consensus estimate of $267.76 million.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Special Reports

Related Entities

JPMorgan, After-Hours Movers

Add Your Comment